CACH/VWM syndrome and leucodystrophies related to EIF2B mutations;Le syndrome CACH/VWM et les leucodystrophies liées à des mutations EIF2B

Revue Neurologique

Volumn 163, Issue 8-9, 2007, Pages 793-799

  Labauge, P ^a   Fogli, A ^b   Niel, F ^c   Rodriguez, D ^d,e   Boespflug Tanguy, O ^b,c  

^a DEPARTMENT OF NEUROLOGY   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CACH; Cree leukoencephalopathy; eIF2B; Orthochromatic leukodystrophy; Ovarioleukodystrophy; VWM

Indexed keywords

CORTICOSTEROID;

ASTROCYTE; BEHAVIOR CHANGE; CELL STRESS; CEREBROSPINAL FLUID; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEAD INJURY; HUMAN; LEUKODYSTROPHY; LEUKOENCEPHALOPATHY; LYMPHOBLAST; MUTATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PROTEIN SYNTHESIS; REVIEW;

EID: 34548661309     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)91461-7     Document Type: Short Survey

References (35)

1. BIANCHERI R, ROSSI A, DI ROCCO M et al. (2003). Leukoencephalopathy with vanishing white matter: an adult onset case. Neurology, 61: 1818-1819.
2. BLUML S, PHILIPPART M, SCHIFFMANN R et al. (2003). Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination. Neurology, 61: 648-654.
3. BLACK DN, BOOTH F, WATTERS GV et al. (1988). Leukoencephalopathy among native Indian infants in northern Quebec and Manitoba. Ann Neurol, 24: 490-496.
4. DIETRICH J, LACAGNINA M, GASS D et al. (2005). EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med, 11: 277-283.
5. FEDERICO A, SCALI O, STROMILLO ML et al. (2006). Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation. Neurology, 67: 353-355.
6. FOGLI A, BOESPFLUG-TANGUY O. (2006). The large spectrum of eIF2B related diseases. Biochem. Soc. Trans, 34: 22-29.
7. FOGLI A, DIONISI-VICI C, F. DEODATO F et al. (2002a). A severe variant of CACH/VWM leukoencephalopathy related to EIF2B5 mutation. Neurology, 59: 1966-68.
8. FOGLI A, WONG K, EYMARD-PIERRE E et al. (2002b). Cree Leukoencephalopathy and Vanishing White Matter Disease are Allelic at the Eucaryotic Translation Initiation Factor 2B5 Locus. Ann Neur, 52: 506-10.
9. FOGLI A, RODRIGUEZ D, EYMARD-PIERRE E et al. (2003a). Ovarian Failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet, 72: 1544-1550.
10. FOGLI A, RODRIGUEZ D, EYMARD-PIERRE E, BOESPFLUG-TANGUY O. (2003b). eIF2B, un facteur d'initiation de la traduction impliqué dans les pathologies de la substance blanche cérébrale. Medecine Sciences, 19: 1-3.
11. FOGLI A, SCHIFFMANN R, BERTINI E et al. (2004a). The Effect of Genotype on the Natural History of eIF2B-Related Leukodystrophies. Neurology, 62: 1509-1517.
12. FOGLI A, SCHIFFMANN R, HUGENDUBLER L et al. (2004b). Decreased Guanine Nucleotide Exchange Factor activity in eIF2B-mutated patients. European Journal Human Genetics, 12: 561-566.
13. FRANCALANCI P, EYMARD-PIERRE E, DIONISI-VICI C et al. (2001). Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology, 57: 265-70.
14. HANEFELD F, HOLZBACH U, KRUSE B et al. (1993). Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics, 24: 244-8.
15. LABAUGE P, GELOT A, FOGLI A et al. (2006). Autosomal dominant leukodystrophy and childhood ataxia with central hypomyelination syndrome. Ann Neurol, in press.
16. LABAUGE P, FOGLI A, CASTELNOVO G et al. (2005). Dominant form of vanishing white matter-like leukoencephalopathy. Ann Neurol, 58: 634-639.
17. LEEGWATER PA, KONST AA, KUYT B et al. (1999). The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27. Am J Hum Genet, 65: 728-34.
18. LEEGWATER PA, VERMEULEN G, KONST AA et al. (2001). Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet, 29: 383-8.
19. LETOURNEL F, ETCHARRY-BOUYX F, VERNY C et al. (2003). Two clinicopathological cases of a dominantly inherited, adult onset orthochromatic leucodystrophy. J Neurol Neurosurg Psychiatry, 74: 671-673.
20. MASCALCHI M, DE GRANDUS D, GINESTRONI A et al. (2006). Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy. Neurology, 67: 537-538.
21. OHTAKE H, SHIMOHATA T, TERAJIMA K et al. (2004). Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology, 62: 1601-1603.
22. RODRIGUEZ D, GELOT A, DELLA GASPERA B et al. (1999). Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol (Berl), 97: 469-80.
23. SCHIFFMANN R, MOLLER JR, TRAPP BD et al. (1994). Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol, 35: 331-40.
24. SCHIFFMANN R, TEDESCHI G, KINKEL RP et al. (1997). Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol,41: 654-661.
25. VAN DER KNAAP MS, BARTH PG, GABREELS FJ et al. (1997). A new leukoencephalopathy with vanishing white matter. Neurology, 48: 845-55.
26. VAN DER KNAAP MS, LEEGWATER PA, KONST AA et al. (2002). Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol, 51: 264-270.
27. VAN DER KNAAP MS, LEEGWATER PA, VAN BERKEL et al. (2004). Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults. Neurology, 62: 1598-1600.
28. VAN DER KNAAP MS, VAN BERKEL CG, HERMS J et al. (2003). eIF2B-Related Disorders: Antenatal Onset and Involvement of Multiple Organs. Am J Hum Genet, 73: 1199-1207.
29. VAN DER VOORN JP, VAN KOLLENBURG B, BERTRAND G et al. (2005). The unfolded protein response in vanishing white matter diease. J Neuropathol Exp Neurol, 64: 770-775.
30. VANDERVER A, SCHIFFMANN R, TIMMONS M et al. (2005). Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. Clin Chem, 51: 2031-2042.
31. VAN KOLLENBURG B, THOMAS AA, VERMEULEN G et al. (2006a). Regulation of protein synthesis in lymphoblasts from vanishing white matter patients. Neurobiol Dis, 21: 496-504.
32. VAN KOLLENBURG B, VAN DIJK J, GARBERN J et al. (2006b). Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol, 65: 707-715.
33. VERGHESE J, WEIDENHEIM K, MALIK S, RAPIN I. (2002). Adult onset pigmentary leukodystrophy with ovarian dysgenesis. Eur J Neurol, 9: 663-670.
34. VERMEULEN G, SEIDL R, MERCIMEK-MAHMUTOGLU S et al. (2005). Frights is a provoking factor in vanishing white matter disease. Ann Neurol, 57: 560-563.
35. WONG K, ARMSTRONG RC, GYURE KA et al. (2000). Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol (Berl), 100: 635-46.